Stay updated on Teriflunomide in Pediatric MS Clinical Trial
Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page
- Check2 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe page has been updated to reflect new dates for optional extension periods for young participants with teriflunomide, moving from 2024 to 2025, indicating a significant change in the timeline for these participants. Additionally, there is a notice regarding heavy traffic affecting NLM-NCBI services.SummaryDifference1%
- Check44 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check95 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.